Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 25 | 2023 | 744 | 1.940 |
Why?
|
| Graft Rejection | 23 | 2024 | 1084 | 1.540 |
Why?
|
| Transplantation Tolerance | 12 | 2024 | 138 | 1.360 |
Why?
|
| B-Lymphocytes | 12 | 2021 | 741 | 1.100 |
Why?
|
| CD40 Ligand | 9 | 2009 | 68 | 1.040 |
Why?
|
| Mice, Inbred C57BL | 23 | 2024 | 3273 | 0.810 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2023 | 452 | 0.790 |
Why?
|
| Isoenzymes | 3 | 2013 | 275 | 0.780 |
Why?
|
| Protein Kinase C | 3 | 2013 | 267 | 0.770 |
Why?
|
| Transplantation, Heterologous | 6 | 2004 | 368 | 0.710 |
Why?
|
| Mice, Inbred BALB C | 15 | 2024 | 1095 | 0.710 |
Why?
|
| Mice | 42 | 2024 | 11932 | 0.660 |
Why?
|
| Obesity | 3 | 2016 | 977 | 0.640 |
Why?
|
| Antibodies, Monoclonal | 10 | 2023 | 1397 | 0.620 |
Why?
|
| Diet, High-Fat | 2 | 2016 | 121 | 0.620 |
Why?
|
| Isoantibodies | 7 | 2021 | 121 | 0.610 |
Why?
|
| T-Lymphocytes | 11 | 2021 | 1228 | 0.580 |
Why?
|
| Transplantation, Homologous | 13 | 2023 | 1001 | 0.560 |
Why?
|
| Galactosyltransferases | 7 | 2004 | 40 | 0.550 |
Why?
|
| Jejunum | 1 | 2016 | 80 | 0.520 |
Why?
|
| Bile Acids and Salts | 1 | 2016 | 69 | 0.520 |
Why?
|
| Animals | 46 | 2024 | 27691 | 0.500 |
Why?
|
| Pancreas Transplantation | 2 | 2008 | 104 | 0.490 |
Why?
|
| Energy Metabolism | 2 | 2016 | 287 | 0.480 |
Why?
|
| Adipose Tissue | 1 | 2016 | 263 | 0.440 |
Why?
|
| Gastrointestinal Tract | 2 | 2016 | 192 | 0.440 |
Why?
|
| NF-kappa B | 4 | 2023 | 469 | 0.420 |
Why?
|
| Immunologic Memory | 8 | 2024 | 165 | 0.420 |
Why?
|
| Spleen | 4 | 2016 | 433 | 0.410 |
Why?
|
| Bone Transplantation | 2 | 2003 | 68 | 0.400 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2024 | 601 | 0.380 |
Why?
|
| Graft Survival | 8 | 2016 | 913 | 0.380 |
Why?
|
| Mice, Knockout | 18 | 2012 | 2033 | 0.380 |
Why?
|
| Glutathione Peroxidase | 1 | 2011 | 24 | 0.370 |
Why?
|
| Skin Transplantation | 4 | 2024 | 187 | 0.370 |
Why?
|
| Basement Membrane | 1 | 2011 | 56 | 0.360 |
Why?
|
| Abatacept | 4 | 2020 | 86 | 0.350 |
Why?
|
| Immunoglobulin G | 6 | 2023 | 472 | 0.340 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2023 | 202 | 0.330 |
Why?
|
| Isoantigens | 4 | 2023 | 71 | 0.320 |
Why?
|
| Oligonucleotides | 1 | 2009 | 92 | 0.320 |
Why?
|
| Immune Tolerance | 8 | 2022 | 344 | 0.320 |
Why?
|
| CpG Islands | 1 | 2009 | 158 | 0.320 |
Why?
|
| Insulin Resistance | 1 | 2011 | 361 | 0.320 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 200 | 0.310 |
Why?
|
| Kidney | 4 | 2011 | 1150 | 0.310 |
Why?
|
| Luminescence | 1 | 2008 | 21 | 0.300 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2006 | 191 | 0.300 |
Why?
|
| Liver | 2 | 2009 | 1216 | 0.270 |
Why?
|
| Mice, Inbred C3H | 5 | 2009 | 371 | 0.270 |
Why?
|
| Insulin-Secreting Cells | 2 | 2006 | 413 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2008 | 566 | 0.250 |
Why?
|
| Rats, Inbred Lew | 7 | 2008 | 197 | 0.250 |
Why?
|
| Lymphocyte Activation | 5 | 2016 | 756 | 0.240 |
Why?
|
| Disaccharides | 4 | 2008 | 23 | 0.240 |
Why?
|
| Interferon-gamma | 4 | 2016 | 449 | 0.230 |
Why?
|
| Lymphocytes | 4 | 2009 | 470 | 0.230 |
Why?
|
| Phenanthrenes | 1 | 2023 | 3 | 0.220 |
Why?
|
| Diterpenes | 1 | 2023 | 22 | 0.220 |
Why?
|
| Killer Cells, Natural | 2 | 2008 | 277 | 0.220 |
Why?
|
| Major Histocompatibility Complex | 1 | 2023 | 84 | 0.220 |
Why?
|
| Prodrugs | 1 | 2023 | 52 | 0.220 |
Why?
|
| Protein Kinase C-theta | 3 | 2013 | 16 | 0.210 |
Why?
|
| Rats | 9 | 2023 | 4059 | 0.200 |
Why?
|
| Interleukin-10 | 1 | 2003 | 155 | 0.200 |
Why?
|
| Liver Transplantation | 1 | 2009 | 1179 | 0.200 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 286 | 0.190 |
Why?
|
| Antigens, Differentiation | 1 | 2002 | 141 | 0.190 |
Why?
|
| Blood Glucose | 4 | 2016 | 846 | 0.190 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2021 | 11 | 0.180 |
Why?
|
| Immunoconjugates | 1 | 2002 | 115 | 0.180 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2023 | 167 | 0.180 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 1583 | 0.170 |
Why?
|
| Allografts | 3 | 2021 | 190 | 0.170 |
Why?
|
| Germinal Center | 1 | 2020 | 55 | 0.170 |
Why?
|
| Signal Transduction | 4 | 2023 | 3426 | 0.170 |
Why?
|
| Fetus | 1 | 2021 | 232 | 0.170 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 135 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 2407 | 0.160 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2016 | 38 | 0.150 |
Why?
|
| Kinetics | 3 | 2016 | 1550 | 0.150 |
Why?
|
| Adoptive Transfer | 4 | 2008 | 169 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 684 | 0.140 |
Why?
|
| CTLA-4 Antigen | 3 | 2009 | 140 | 0.140 |
Why?
|
| Central Tolerance | 1 | 2016 | 8 | 0.140 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2023 | 117 | 0.130 |
Why?
|
| Gastrointestinal Hormones | 1 | 2016 | 6 | 0.130 |
Why?
|
| Adipokines | 1 | 2016 | 17 | 0.130 |
Why?
|
| Immunosuppressive Agents | 2 | 2016 | 984 | 0.130 |
Why?
|
| Receptors, IgG | 2 | 2008 | 54 | 0.130 |
Why?
|
| Adiposity | 1 | 2016 | 76 | 0.130 |
Why?
|
| Thermogenesis | 1 | 2016 | 45 | 0.130 |
Why?
|
| Antigens, CD | 3 | 2009 | 467 | 0.130 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 142 | 0.130 |
Why?
|
| Complement Activation | 2 | 2008 | 81 | 0.130 |
Why?
|
| Time Factors | 6 | 2016 | 5365 | 0.130 |
Why?
|
| Swine | 5 | 2004 | 593 | 0.130 |
Why?
|
| Phenotype | 3 | 2016 | 2471 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2016 | 295 | 0.120 |
Why?
|
| Lipids | 1 | 2016 | 276 | 0.120 |
Why?
|
| Trisaccharides | 3 | 2003 | 12 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 78 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 860 | 0.110 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2006 | 243 | 0.110 |
Why?
|
| Rituximab | 1 | 2013 | 120 | 0.100 |
Why?
|
| Listeriosis | 2 | 2015 | 86 | 0.100 |
Why?
|
| Listeria monocytogenes | 2 | 2015 | 93 | 0.100 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2012 | 4 | 0.100 |
Why?
|
| Antibody Formation | 3 | 2020 | 172 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 2337 | 0.100 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 2009 | 73 | 0.100 |
Why?
|
| Transplantation, Heterotopic | 4 | 2009 | 46 | 0.100 |
Why?
|
| Seminiferous Tubules | 1 | 2011 | 8 | 0.090 |
Why?
|
| Epididymis | 1 | 2011 | 19 | 0.090 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2011 | 18 | 0.090 |
Why?
|
| Gastric Bypass | 1 | 2012 | 113 | 0.090 |
Why?
|
| Mice, Inbred NOD | 2 | 2008 | 199 | 0.090 |
Why?
|
| Weight Loss | 1 | 2012 | 234 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1688 | 0.090 |
Why?
|
| Bronchi | 1 | 2011 | 230 | 0.090 |
Why?
|
| Male | 8 | 2024 | 42931 | 0.080 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2016 | 526 | 0.080 |
Why?
|
| Mice, Inbred Strains | 2 | 2015 | 309 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2011 | 791 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 40 | 0.080 |
Why?
|
| Inflammation | 2 | 2016 | 990 | 0.080 |
Why?
|
| Cytokines | 2 | 2002 | 813 | 0.080 |
Why?
|
| Luciferases | 1 | 2008 | 128 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 441 | 0.070 |
Why?
|
| Immunoglobulin M | 3 | 2002 | 164 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2009 | 694 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 277 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2011 | 693 | 0.070 |
Why?
|
| Epitopes | 2 | 2004 | 254 | 0.070 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 232 | 0.070 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 26 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2006 | 47 | 0.070 |
Why?
|
| Injections, Intravenous | 2 | 2003 | 238 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 662 | 0.060 |
Why?
|
| Cell Differentiation | 3 | 2006 | 1547 | 0.060 |
Why?
|
| Pregnancy | 2 | 2024 | 3064 | 0.060 |
Why?
|
| Female | 11 | 2024 | 46855 | 0.060 |
Why?
|
| Recurrence | 1 | 2008 | 1162 | 0.060 |
Why?
|
| Acute Disease | 2 | 2009 | 854 | 0.060 |
Why?
|
| Isoxazoles | 1 | 2005 | 77 | 0.060 |
Why?
|
| Histocompatibility | 1 | 2004 | 65 | 0.060 |
Why?
|
| Epoxy Compounds | 1 | 2023 | 9 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 1 | 2005 | 153 | 0.060 |
Why?
|
| Galactose | 1 | 2003 | 32 | 0.050 |
Why?
|
| Immune Sera | 1 | 2003 | 52 | 0.050 |
Why?
|
| Clonal Deletion | 1 | 2003 | 23 | 0.050 |
Why?
|
| Cloning, Organism | 1 | 2003 | 19 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2003 | 48 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 101 | 0.050 |
Why?
|
| Ricin | 1 | 2002 | 6 | 0.050 |
Why?
|
| beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase | 1 | 2002 | 2 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2006 | 1708 | 0.050 |
Why?
|
| Transplantation Chimera | 1 | 2002 | 81 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2002 | 150 | 0.050 |
Why?
|
| Transplantation Immunology | 1 | 2002 | 82 | 0.050 |
Why?
|
| Antigens | 1 | 2002 | 229 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2002 | 166 | 0.050 |
Why?
|
| Th2 Cells | 1 | 2002 | 147 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2005 | 487 | 0.050 |
Why?
|
| Myocardium | 1 | 2004 | 574 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 437 | 0.040 |
Why?
|
| Body Weight | 2 | 2016 | 455 | 0.040 |
Why?
|
| Bortezomib | 1 | 2020 | 80 | 0.040 |
Why?
|
| Apoptosis | 2 | 2023 | 1723 | 0.040 |
Why?
|
| Humans | 8 | 2023 | 90568 | 0.040 |
Why?
|
| Peptides | 1 | 2023 | 661 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 524 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2003 | 511 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 2607 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 746 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2016 | 14 | 0.030 |
Why?
|
| Thymocytes | 1 | 2016 | 31 | 0.030 |
Why?
|
| Integrases | 1 | 2016 | 63 | 0.030 |
Why?
|
| Cytidine Deaminase | 1 | 2016 | 43 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2002 | 703 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 65 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 2016 | 31 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 144 | 0.030 |
Why?
|
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2015 | 11 | 0.030 |
Why?
|
| 5'-Nucleotidase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Hybridomas | 2 | 2008 | 75 | 0.030 |
Why?
|
| Autoantigens | 1 | 2016 | 132 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 866 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 3029 | 0.030 |
Why?
|
| Immunization | 2 | 2004 | 163 | 0.030 |
Why?
|
| Heart | 1 | 2016 | 580 | 0.030 |
Why?
|
| Models, Animal | 2 | 2004 | 278 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 1855 | 0.020 |
Why?
|
| Interleukin-2 | 2 | 2002 | 241 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 168 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 373 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 903 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 29 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2008 | 53 | 0.020 |
Why?
|
| Bystander Effect | 1 | 2008 | 12 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2008 | 26 | 0.020 |
Why?
|
| Hemolysin Proteins | 1 | 2008 | 34 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2076 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2008 | 72 | 0.020 |
Why?
|
| Cell Line | 2 | 2003 | 2505 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2008 | 49 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2008 | 101 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2008 | 143 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2008 | 82 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2008 | 93 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 115 | 0.020 |
Why?
|
| Interferon Type I | 1 | 2008 | 187 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 183 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 987 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2006 | 260 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2005 | 38 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 309 | 0.020 |
Why?
|
| Alkynes | 1 | 2005 | 19 | 0.020 |
Why?
|
| Regeneration | 1 | 2006 | 151 | 0.010 |
Why?
|
| Uridine | 1 | 2005 | 57 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2006 | 172 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 558 | 0.010 |
Why?
|
| Nitriles | 1 | 2005 | 156 | 0.010 |
Why?
|
| Membranes | 1 | 2004 | 37 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 380 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 2003 | 40 | 0.010 |
Why?
|
| Virus Replication | 1 | 2005 | 326 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 2003 | 20 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 2003 | 49 | 0.010 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2003 | 15 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 2003 | 38 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2892 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 2003 | 59 | 0.010 |
Why?
|
| Lymphocyte Transfusion | 1 | 2002 | 41 | 0.010 |
Why?
|
| Antigens, Heterophile | 1 | 2002 | 6 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 223 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2003 | 255 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 9323 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2002 | 129 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 1049 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 549 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 353 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 602 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 764 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 683 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2003 | 337 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 728 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1247 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 26327 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 26940 | 0.010 |
Why?
|